Flagship Ventures 2007 General Partner LLC
Follow13F filer, CIK 1508053, CAMBRIDGE, MA
Flagship Ventures 2007 General Partner LLC reported $152,401,000 across 4 holdings for the quarter ended 2015-12-31, in a 13F-HR filed 2016-02-12.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001012975-16-001004
- Period
- 2015-12-31
- Reported value
- $152M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RENEWABLE ENERGY GROUP INCadded | +1,239 | $11.5K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BG MEDICINE INCexited | -441,072 | -$181K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2015
Share positions as resolved from 13F-HR 0001012975-16-001004, largest first. % of portfolio is the value over $152,401,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| AGIOAGIOS PHARMACEUTICALS INC | 1,930,369 | $125M | 82.23% | 0 | Timeline | ||
| SERES THERAPEUTICS INCSERES THERAPEUTICS INC | 599,297 | $21M | 13.8% | 0 | |||
| SESEN BIO, INC.SESEN BIO, INC. | 1,907,008 | $5.74M | 3.77% | 0 | |||
| RENEWABLE ENERGY GROUP INCRENEWABLE ENERGY GROUP INC | 33,570 | $312K | 0.2% | +1,239 |
Sold out in Q4 2015
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| BG MEDICINE INCBG MEDICINE INC | 441,072 | $181K | shares |
How Q4 2015 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001012975-16-001004 | base | 2016-02-12 | acceptance time not in the bulk data set |